BAK Braskem S.A. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
BAK Stock | Fundamental Analysis & Investment Insights
NYSE
Basic Materials
Chemicals
Current Price
Live
$3.63
Analyst Target
$3.67
+1.2%
Upside
52W High
$5.1
52W Low
$2.32
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
85%
Analysis Accuracy
The deterministic health scores paint a deeply concerning picture: BAK has a Piotroski F-Score of just 1/9, indicating severe financial weakness. Despite a recent short-term price rebound, the company is unprofitable, deeply leveraged, and experiencing sharp revenue and earnings declines. Negative margins, deteriorating cash flows, and inconsistent earnings surprises further undermine any valuation appeal. While the insider sentiment is neutral and analysts recommend a hold, the fundamental trajectory remains negative with no clear path to recovery.
Key Strengths
Recent short-term price momentum: +17.9% over 1 month and +10.3% over 6 months suggest possible speculative or cyclical rebound.
Low Price/Sales ratio of 0.02 indicates the market prices BAK extremely cheaply relative to sales, potentially pricing in worst-case scenarios.
Current Ratio of 1.18 shows minimal short-term liquidity coverage, avoiding immediate technical insolvency.
Analyst target price of $3.67 is marginally above current price ($3.63), implying limited near-term downside according to consensus.
Some recent earnings surprises were positive (e.g., +130.9% in Q3 2023), suggesting potential for volatility-driven rallies.
Key Risks
Piotroski F-Score of 1/9 signals extreme financial distress—among the weakest possible fundamental health profiles.
Negative Profit Margin (-7.11%) and Operating Margin (-9.65%) reflect ongoing unprofitability and poor cost control.
Price/Book of -4.33 indicates negative book value, a red flag for solvency and asset-backed value.
Revenue Growth YoY of -18.60% shows steep top-line contraction, worsening an already fragile position.
Quick Ratio of 0.56 suggests inadequate liquid assets to cover short-term liabilities, raising liquidity concerns.
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare BAK against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning BAK from our newsroom.
Newest → oldest
No matching news yet.